SCHEMBL793866

SCHEMBL793866

O=c1[nH]ccc2c1sc1ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 3/20 0.51
TNKS2 Q9H2K2 3/20 0.51
GPR3 P46089 1/20 0.46
PARP1 P09874 4/20 0.46
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 3/20 0.42
LMNA P02545 2/20 0.42
RAB9A P51151 2/20 0.42
HPGD P15428 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
BLM P54132 1/20 0.42
PARP15 Q460N3 1/20 0.42
HSD17B10 Q99714 1/20 0.42
RECQL P46063 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MAPT P10636 2/20 0.41
HTT P42858 2/20 0.41
DDAH1 O94760 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20427271 0.76 MAPT (0.47) TNKSTNKS2GPR3ALDH1A1KDM4E
SCHEMBL793946 0.74 MAPT (0.47) TNKSTNKS2GPR3PARP1ALDH1A1
SCHEMBL21243890 0.73 PARP1 (0.40) TNKSTNKS2PARP1ALDH1A1KDM4E
SCHEMBL15497424 0.73 GPR3 (0.68) TNKSTNKS2GPR3ALDH1A1KDM4E
SCHEMBL1039859 0.73 GPR3 (0.68) TNKSTNKS2GPR3ALDH1A1KDM4E
SCHEMBL23842973 0.72 GPR3 (0.54) TNKSTNKS2GPR3PARP1ALDH1A1
SCHEMBL15684376 0.71 MAPT (0.46) TNKSTNKS2GPR3PARP1ALDH1A1
SCHEMBL4074785 0.70 MEN1 (0.62) TNKSTNKS2GPR3PARP1ALDH1A1
SCHEMBL18647351 0.70 MEN1 (0.53) TNKSTNKS2GPR3PARP1ALDH1A1
SCHEMBL4208864 0.70 KRAS (0.51) TNKSTNKS2PARP1KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2627648-A1 17aHYDROXYLASE/C17,20-LYASE INHIBITORS Novartis AG (CH) 2013-08-21 EP disclosed
WO-2012035078-A1 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS NOVARTIS AG (CH) 2012-03-22 WO disclosed